T.T. Wind


  1. Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program

    Bisschop, C., Wind, T. T., Blank, C. U., Koornstra, R. H. T., Kapiteijn, E., Van den Eertwegh, A. J. M., De Groot, J. W. B., Jalving, M. & Hospers, G. A. P., 2019, In : Journal of Immunotherapy. 42, 6, p. 208-214 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (8) »

ID: 24023636